Vivanza Biosciences reschedules its board meeting from May 4 to May 7, 2026 to approve audited results.
The meeting will consider audited standalone and consolidated financial results for Q4 and year ended March 31, 2026.
The trading window remains closed until 48 hours after the declaration of the financial results.